Skip to main content
Top
Published in: Endocrine 2/2013

01-04-2013 | Editorial

Role of glycemic variability in gestational diabetes mellitus (GDM): still an uphill climb

Authors: Annunziata Lapolla, Nino Cristiano Chilelli

Published in: Endocrine | Issue 2/2013

Login to get access

Excerpt

Insulin resistance tends to increase in physiological pregnancy because of the gradually rising levels of feto-placental hormones such as progesterone, cortisol, growth hormone, prolactin, and human placental lactogen. In response to this imbalance, the pancreas normally compensates with a higher insulin secretion. When this compensatory mechanism fails, glucose intolerance develops and, in pregnancy, this is called gestational diabetes mellitus (GDM) [1]. The resulting maternal hyperglycemia gives rise to a concomitant fetal hyperinsulinemia via the placenta, leading primarily to fetal macrosomia, which is the main cause of well-known complications relating to the fetus’s development (e.g., shoulder dystocia, Erb’s paralysis, hypoxia, and acidosis) and to the course of labor (e.g., perineal laceration, cesarean section) [2]. …
Literature
1.
go back to reference A. Lapolla, M.G. Dalfrà, G. Mello et al., Early detection of insulin sensitivity and beta cell function with simple tests indicate future derangements in late pregnancy. J. Clin. Endocrinol. Metab. 93, 876–880 (2008)PubMedCrossRef A. Lapolla, M.G. Dalfrà, G. Mello et al., Early detection of insulin sensitivity and beta cell function with simple tests indicate future derangements in late pregnancy. J. Clin. Endocrinol. Metab. 93, 876–880 (2008)PubMedCrossRef
2.
go back to reference A. Lapolla, M.G. Dalfrà, D. Fedele, Management of gestational diabetes mellitus. Diabetes Metab. Syndr. Obes. 17, 73–82 (2009)CrossRef A. Lapolla, M.G. Dalfrà, D. Fedele, Management of gestational diabetes mellitus. Diabetes Metab. Syndr. Obes. 17, 73–82 (2009)CrossRef
3.
go back to reference HAPO Study Cooperative Research Group, B.E. Metzger, L.P. Lowe, A.R. Dyer et al., Hyperglycemia and adverse pregnancy outcomes. N. Engl. J. Med. 358, 1991–2002 (2008)PubMedCrossRef HAPO Study Cooperative Research Group, B.E. Metzger, L.P. Lowe, A.R. Dyer et al., Hyperglycemia and adverse pregnancy outcomes. N. Engl. J. Med. 358, 1991–2002 (2008)PubMedCrossRef
4.
go back to reference L. Nalysnyk, M. Hernandez-Medina, G. Krishnarajah, Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature. Diabetes Obes. Metab. 12, 288–298 (2010)PubMedCrossRef L. Nalysnyk, M. Hernandez-Medina, G. Krishnarajah, Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature. Diabetes Obes. Metab. 12, 288–298 (2010)PubMedCrossRef
5.
go back to reference C.M. Chang, C.J. Hsieh, J.C. Huang, I.C. Huang, Acute and chronic fluctuations in blood glucose levels can increase oxidative stress in type 2 diabetes mellitus. Acta Diabetol. (2012). doi:10.1007/s00592-012-0398-x C.M. Chang, C.J. Hsieh, J.C. Huang, I.C. Huang, Acute and chronic fluctuations in blood glucose levels can increase oxidative stress in type 2 diabetes mellitus. Acta Diabetol. (2012). doi:10.​1007/​s00592-012-0398-x
6.
go back to reference L. Jovanovic, Continuous glucose monitoring during pregnancy complicated by gestational diabetes mellitus. Curr. Diabetes Rep. 1, 82–85 (2001)CrossRef L. Jovanovic, Continuous glucose monitoring during pregnancy complicated by gestational diabetes mellitus. Curr. Diabetes Rep. 1, 82–85 (2001)CrossRef
7.
go back to reference M.G. Dalfrà, G. Sartore, G. Di Cianni, G. Mello, C. Lencioni, S. Ottanelli, J. Sposato, F. Valgimigli, C. Scuffi, M. Scalese, A. Lapolla, Glucose variability in diabetic pregnancy. Diabetes Technol. Ther. 13, 853–859 (2011)PubMedCrossRef M.G. Dalfrà, G. Sartore, G. Di Cianni, G. Mello, C. Lencioni, S. Ottanelli, J. Sposato, F. Valgimigli, C. Scuffi, M. Scalese, A. Lapolla, Glucose variability in diabetic pregnancy. Diabetes Technol. Ther. 13, 853–859 (2011)PubMedCrossRef
8.
go back to reference J.B. Su, X.Q. Wang, J.F. Chen, G. Wu, Y. Jin, F. Xu, X.H. Wang, Y.T. Liu, Glycemic variability in gestational diabetes mellitus and its association with β cell function. Endocrine (2012). doi:10.1007/s12020-012-9753-5 J.B. Su, X.Q. Wang, J.F. Chen, G. Wu, Y. Jin, F. Xu, X.H. Wang, Y.T. Liu, Glycemic variability in gestational diabetes mellitus and its association with β cell function. Endocrine (2012). doi:10.​1007/​s12020-012-9753-5
9.
go back to reference K.D. Kohnert, P. Augstein, E. Zander, P. Heinke, K. Peterson, E.J. Freyse, R. Hovorka, E. Salzsieder, Glycemic variability correlates strongly with postprandial beta-cell dysfunction in a segment of type 2 diabetic patients using oral hypoglycemic agents. Diabetes Care 32, 1058–1062 (2009)PubMedCrossRef K.D. Kohnert, P. Augstein, E. Zander, P. Heinke, K. Peterson, E.J. Freyse, R. Hovorka, E. Salzsieder, Glycemic variability correlates strongly with postprandial beta-cell dysfunction in a segment of type 2 diabetic patients using oral hypoglycemic agents. Diabetes Care 32, 1058–1062 (2009)PubMedCrossRef
10.
go back to reference G. Sartore, N.C. Chilelli, S. Burlina, P.D. Stefano, F. Piarulli, D. Fedele, A. Mosca, A. Lapolla, The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM). Acta Diabetol. (2012). doi:10.1007/s00592-012-0391-4 G. Sartore, N.C. Chilelli, S. Burlina, P.D. Stefano, F. Piarulli, D. Fedele, A. Mosca, A. Lapolla, The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM). Acta Diabetol. (2012). doi:10.​1007/​s00592-012-0391-4
Metadata
Title
Role of glycemic variability in gestational diabetes mellitus (GDM): still an uphill climb
Authors
Annunziata Lapolla
Nino Cristiano Chilelli
Publication date
01-04-2013
Publisher
Springer US
Published in
Endocrine / Issue 2/2013
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-012-9807-8

Other articles of this Issue 2/2013

Endocrine 2/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.